# Pharmacogenomic Testing in Major Depressive Disorder

> **NCT03228953** · NA · TERMINATED · sponsor: **Columbia University** · enrollment: 38 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **OTHER:** Pharmacogenomic testing

## Key facts

- **NCT ID:** NCT03228953
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-08-01
- **Primary completion:** 2019-07-17
- **Final completion:** 2019-07-17
- **Target enrollment:** 38 (ACTUAL)
- **Why stopped:** Investigator retired.
- **Last updated:** 2022-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03228953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03228953, "Pharmacogenomic Testing in Major Depressive Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03228953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*